Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 587,500 shares, an increase of 7.4% from the April 15th total of 547,200 shares. Currently, 2.7% of the company’s shares are short sold. Based […]